Etusivu » Finnish Medical Journal » English summaries

English summaries

Bleeding risk in connection with gastrointestinal endoscopy and endoscopic procedures
Julkaistu 07.05.2010 00.01

The risk of acute haemorrhage after gastrointestinal endoscopy and biopsy is usually low. Endoscopic procedures such as polypectomy and dilatation of strictures increase the likelihood of overt bleeding, especially in patients with anticoagulant or antiplatelet drug therapy. On the other hand, the discontinuation of these drugs may result in thrombotic complications. Aspirin withdrawal is usually not necessary before endoscopy, provided that there are no other risk factors present. In procedures with a low risk of bleeding antithrombotic treatment can usually be continued, but the INR level should be checked prior to the procedure, whereas in high-risk procedures, warfarin and clopidogrel should be temporarily discontinued. However, if the risk of thrombosis after stopping antithrombotic therapy outweighs the risk of haemorrhage, warfarin should be temporarily replaced by low molecular weight heparin (bridge therapy). Discontinuation of clopidogrel therapy is not safe within six weeks to three months after placement of bare metal coronary stent and within 12 months after placement of drug-eluting coronary stent; clopidogrel withdrawal should thus be considered only after consulting the cardiologist. Discussion with the haematologist is necessary if the patient suffers from von Willebrand’s disease or from haemophilia.

Co-existing liver failure or uraemia increases the bleeding risk, and heart failure, atrial fibrillation or previous thromboembolic complication or stroke increases the risk of thrombosis, if antithrombotic therapy is discontinued. The medical condition of the patient should be assessed on an individual basis when weighing up the benefits and risks of gastrointestinal endoscopic procedures.

Pekka Collin

Docent, Head of Department

Tampere University Hospital, Department of Gastroenterology

Pekka.collin@uta.fi

Markku Peräaho, Martti Färkkilä, Markku Heikkinen, Rauli Leino, Seppo Niemelä

Finnish Medical Journal 2010;65:1613–6.

 

Previous Next More news  
Käynnistä keskustelu aiheesta Kerro kollegalle Tulosta

Kerro kollegalle

Lähetä uutinen sähköpostilla


Uusimmat uutiset

The Pirkkala Model – Working with doctor-nurse teams and patient listing at a health centre 10.09.2010

An outbreak of seasonal influenza in a healthcare centre ward: recommendations for prevention and control 10.09.2010

Fluorescence cystoscopy in diagnosis and management of superficial bladder cancer03.09.2010

When should ankle sprains be treated surgically?03.09.2010

MUST- Clinical practice in Multiple Sclerosis Treatment in Finland 2007, a registry based study: Finnish neurologist notice Current Care guidelines for the treatment of MS patient03.09.2010

In search of hidden motivation. Solution-focused facilitation of health- and weight-related behavior change27.08.2010

Is alcohol consumption a risk factor for obesity?27.08.2010

Overweight and obesity in 2- to 7-year-old children27.08.2010

The healthier future resides in family meals; The Diet of Finnish Preschoolers27.08.2010

Rehabilitation of elective thoracotomy patients13.08.2010

Suomen Lääkärilehti
Mäkelänkatu 2, PL 49, 00501 Helsinki
Puh. (09) 393 091, Fax (09) 393 0794
laakarilehti@fimnet.fi
© Suomen Lääkärilehti 1998-2010